Finance

Lists
Why is SDZNY up 2,14%?
Dive Deeper
SDZNY:OTCMKTS
SANDOZ GROUP ADR
92,98 US$
+2,14%
(+1,94) 1D
16 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDZNY...
Open
92,15 US$
High
93,52 US$
Low
92,15 US$
Mkt. cap
33,64 მლრდ.
Avg. vol.
27,16 ათ.
Volume
24,96 ათ.
52-wk high
94,15 US$
52-wk low
60,40 US$
Shares outstanding
440,00 მლნ.
No. of employees
20 ათ.
Open
92,15 US$
High
93,52 US$
Low
92,15 US$
Mkt. cap
33,64 მლრდ.
Avg. vol.
27,16 ათ.
Volume
24,96 ათ.
52-wk high
94,15 US$
52-wk low
60,40 US$
Shares outstanding
440,00 მლნ.
No. of employees
20 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
15 საათის წინ
Sandoz stock heads into the next Xetra session at EUR 82.86
ad-hoc-news.de
ad-hoc-news.de
·
1 დღის წინ
Sandoz stock: October 28 results are due for Sandoz stock
ad-hoc-news.de
ad-hoc-news.de
·
1 დღის წინ
Sandoz stock pre-market at EUR 81.94
ad-hoc-news.de
ad-hoc-news.de
·
2 დღის წინ
Barclays keeps CHF 93.00 target for Sandoz stock
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR
CEOრიჩარდ სეინორ
Employees20 ათ.
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,95 მლრდ.
2,95 მლრდ.
2,89 მლრდ.
2,89 მლრდ.
Cost of goods sold
1,50 მლრდ.
1,50 მლრდ.
1,52 მლრდ.
1,52 მლრდ.
Cost of revenue
1,50 მლრდ.
1,50 მლრდ.
1,52 მლრდ.
1,52 მლრდ.
Research and development expenses
272,00 მლნ.
272,00 მლნ.
253,50 მლნ.
253,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
668,50 მლნ.
668,50 მლნ.
680,00 მლნ.
680,00 მლნ.
Operating expense
1,02 მლრდ.
1,02 მლრდ.
1,23 მლრდ.
1,23 მლრდ.
Total operating expenses
2,52 მლრდ.
2,52 მლრდ.
2,74 მლრდ.
2,74 მლრდ.
Operating income
421,50 მლნ.
421,50 მლნ.
151,50 მლნ.
151,50 მლნ.
Other non operating income
-28,00 მლნ.
-28,00 მლნ.
-
-
EBT including unusual items
351,50 მლნ.
351,50 მლნ.
69,00 მლნ.
69,00 მლნ.
EBT excluding unusual items
367,50 მლნ.
367,50 მლნ.
97,50 მლნ.
97,50 მლნ.
Income tax expense
83,00 მლნ.
83,00 მლნ.
14,50 მლნ.
14,50 მლნ.
Effective tax rate
23,61%
23,61%
21,01%
21,01%
Other operating expenses
82,50 მლნ.
82,50 მლნ.
292,00 მლნ.
292,00 მლნ.
Net income
268,50 მლნ.
268,50 მლნ.
54,50 მლნ.
54,50 მლნ.
Net profit margin
9,11%
9,11%
1,88%
1,88%
Earnings per share
-
-
-
-
Interest and investment income
23,50 მლნ.
23,50 მლნ.
-
-
Interest expense
-54,50 მლნ.
-54,50 მლნ.
-54,00 მლნ.
-54,00 მლნ.
Net interest expenses
-31,00 მლნ.
-31,00 მლნ.
-54,00 მლნ.
-54,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
531,00 მლნ.
531,00 მლნ.
284,50 მლნ.
284,50 მლნ.
Gain or loss from assets sale
-3,00 მლნ.
-3,00 მლნ.
-16,00 მლნ.
-16,00 მლნ.
AI content may include mistakes. Learn more
Google აპები